AlphaYouJF
Insider selling
John F. Paolini sold $3.1M of Kiniksa Pharmaceuticals International, plc (KNSA) stock
John F. Paolini, Chief Medical Officer of Kiniksa Pharmaceuticals International, plc (KNSA), sold 58,424 shares of KNSA stock worth $3.1M, per an SEC Form 4 filed May 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 1, 2026, 4 days before it was made public.
KNSA has moved +41.4% since the trade date, from $55.27 to $78.13 (Sep 21, 2026 close).
- Traded
- May 1, 2026
- Disclosed
- May 5, 2026
- Filing delay
- 4 days
- Price since
- +41.4%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More KNSA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.